Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA) administered by parenteral or mucosal routes against Brucella ovis in BALB/c mice.
Sign Up to like & getrecommendations! Published in 2022 at "Research in veterinary science"
DOI: 10.1016/j.rvsc.2022.02.001
Abstract: Brucella ovis is an economically important cause of epididymitis in rams worldwide. Polymeric BLSOmp31 was previously identified as a protective immunogen against this pathogen. In this study, BLSOmp31 was formulated with a modified version of… read more here.
Keywords: mice; ispa administered; blsomp31 formulated; blsomp31 ... See more keywords